Skip to main content

Diagnosis News

Related terms: Diagnose, Diagnosed

FDA Approves Gadavist (gadobutrol) as the First MRI Contrast Agent for Patients Less Than 2 Years

LEVERKUSEN, Germany, Jan. 5, 2015 /PRNewswire/ – Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic...

Ask a question

To post your own question to this support group, sign in or create an account.